We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nicox Sa | LSE:0RCQ | London | Ordinary Share | FR0013018124 | NICOX ORD SHS |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
5.53 | 5.81 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 7.14M | -20.88M | -0.4162 | -13.62 | 284.46M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
11:54:24 | O | 2,064 | 0.262 | EUR |
Date | Time | Source | Headline |
---|---|---|---|
23/9/2024 | 06:30 | UKREG | Nicox et Glaukos signent un accord exclusif de recherche incluant une.. |
23/9/2024 | 06:30 | UKREG | Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing.. |
18/9/2024 | 06:30 | UKREG | Nicox annonce l’approbation de ZERVIATE en Chine |
18/9/2024 | 06:30 | UKREG | Nicox Announces Approval of ZERVIATE in China |
04/9/2024 | 06:30 | UKREG | Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps.. |
04/9/2024 | 06:30 | UKREG | Nicox nomme Christine Placet administrateur ; Michele Garufi se retire du.. |
25/7/2024 | 06:30 | UKREG | Nicox Announces Recruitment of Last Patient in U.S. in Denali Phase 3 Trial.. |
25/7/2024 | 06:30 | UKREG | Nicox : Recrutement du dernier patient aux Etats- Unis dans l’étude.. |
19/7/2024 | 06:30 | UKREG | Nicox announces attendance at upcoming conferences |
19/7/2024 | 06:30 | UKREG | Nicox : Participation aux prochaines conférences |
Nicox (0RCQ) Share Charts1 Year Nicox Chart |
|
1 Month Nicox Chart |
Intraday Nicox Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions